Abstract:As deaths from acute myocardial infarction have declined dramatically over the past several decades, more and more patients survive with chronic myocardial ischemia.1,2 Hearts of most patients who survive acute myocardial infarction undergo remodeling. Hearts of most patients with sustained hypertension, another common cardiovascular disease, also show some degree of remodeling. The heart consists of 3 primary cell types: cardiomyocytes, fibroblasts, and endothelial cells. Myocytes occupy 75% of cardiac mass, generate the electric impulses, and induce cardiac contraction. Fibroblasts are primarily responsible for the maintenance of extracellular matrix (ECM) that is composed of collagens, fibronectins, elastins, fibrillins, and several other proteins. The capillary microcirculation network composed primarily of endothelial cells that serves the contractile assembly.3 In state of health, renin–angiotensin–aldosterone system is thought to be responsible for sustenance of cardiomyocyte, fibroblast, and endothelial cell biology. However, renin–angiotensin–aldosterone system activation leads to profound changes in cell biology during sustained hypoxia. Cardiomyocytes in the regions adjacent to ischemic area become large to maintain cardiac contraction. Fibroblasts around the cardiomyocytes begin to grow and differentiate into myofibroblasts to compensate for low-cardiac output. This process of cardiomyocyte hypertrophy and cardiac fibroblast growth is commonly known as cardiac remodeling.4–6 Release of large amounts of reactive oxygen species in the ischemic myocardium and the associated inflammatory response are thought to be mechanistic contributors to cardiac remodeling. Local activation of renin–angiotensin–aldosterone system contributes to further reactive oxygen species generation and release of transforming growth factor-β (TGF-β); the latter plays a central role in fibroblast transformation into myofibroblasts and subsequent activation of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and synthesis of collagens.7 MMPs and TIMPs mediate the balance between formation of collagens and their degradation, and their abnormal expression promotes secretion of large amounts of collagens by rapidly …

The Molecular Mechanism of Different Factors Caused Myocardial Fibrosis

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Ethyl Ferulate suppresses Post-Myocardial Infarction Myocardial Fibrosis by Inhibiting Transforming Growth Factor Receptor 1

Myocardial fibrosis in right heart dysfunction

Research Progress of Traditional Chinese Medicine Based on TGF-β/Smad Signal Pathway in Preventing and Treating Myocardial Fibrosis in Heart Failure

Proteomic Insights into Cardiac Fibrosis: from Pathophysiological Mechanisms to Therapeutic Opportunities

Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms

Targeted myocardial fibrosis for improving the diagnosis and treatment of heart failure

Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure

Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway

Relationship Between Platelet-Derived Growth Factors and Myocardial Fibrosis

Noncoding RNAs and Cardiac Fibrosis

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

TGF- Β1 of Cardiac Tissue and Ventricular Remodeling in Rats with Acute Myocardial Infarction

Atrial fibrosis and tissue remodeling:the role of transforming growth factor-beta1 and other neurohormonal media

The role and mechanism of transforming growth factor beta 3 in human myocardial infarction‐induced myocardial fibrosis

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis

Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact

The Mechanism of SIRT3 Regulating SRV2-Mediated Mitochondrial Fission of Fibroblasts to Inhibit Myocardial Fibrosis after Acute Myocardial Infarction

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

Cardiac fibrosis.